Bills To Speed Generic Entry Once Again Clear Senate Judiciary Committee

Legislation to prevent pay-for-delay deals, product hopping and sham citizen petitions, and to require the FTC to study the role of pharmacy benefit managers in the drug supply chain get unanimous committee vote. They may have a good shot at passage given recent actions by President Biden and the FTC, and bipartisan interest in drug pricing.

US Congress building
Senate Judiciary Committee advances bills to decrease prescription drug costs • Source: Alamy

The Senate Judiciary Committee has cleared four bills intended to address the high prices of prescription drugs by prohibiting practices that delay the launch of generic products. The bills now go to the Senate floor where they have a chance of passage given recent actions by the Biden Administration, the US Federal Trade Commission, and bipartisan interest in drug pricing.

Versions of the bills – which address so-called pay-for-delay deals, product hopping, citizen petitions to the US Food and Drug...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet